Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America In Vitro Toxicity Testing Market, by Type
1.4.2 North America In Vitro Toxicity Testing Market, by Technology
1.4.3 North America In Vitro Toxicity Testing Market, by End User
1.4.4 North America In Vitro Toxicity Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America In Vitro Toxicity Testing Market by Type
3.1 North America Absorption Market by Country
3.2 North America Toxic Substances Market by Country
3.3 North America Dose Market by Country
Chapter 4. North America In Vitro Toxicity Testing Market by Technology
4.1 North America Cell Culture Technologies Market by Country
4.2 North America High Throughput Technologies Market by Country
4.3 North America Toxicogenomics Market by Country
Chapter 5. North America In Vitro Toxicity Testing Market by End User
5.1 North America Cosmetics & Households Products Market by Country
5.2 North America Pharmaceuticals Industry Market by Country
5.3 North America Food Industry Market by Country
5.4 North America Chemicals Industry Market by Country
Chapter 6. North America In Vitro Toxicity Testing Market by Country
6.1 US In Vitro Toxicity Testing Market
6.1.1 US In Vitro Toxicity Testing Market by Type
6.1.2 US In Vitro Toxicity Testing Market by Technology
6.1.3 US In Vitro Toxicity Testing Market by End User
6.2 Canada In Vitro Toxicity Testing Market
6.2.1 Canada In Vitro Toxicity Testing Market by Type
6.2.2 Canada In Vitro Toxicity Testing Market by Technology
6.2.3 Canada In Vitro Toxicity Testing Market by End User
6.3 Mexico In Vitro Toxicity Testing Market
6.3.1 Mexico In Vitro Toxicity Testing Market by Type
6.3.2 Mexico In Vitro Toxicity Testing Market by Technology
6.3.3 Mexico In Vitro Toxicity Testing Market by End User
6.4 Rest of North America In Vitro Toxicity Testing Market
6.4.1 Rest of North America In Vitro Toxicity Testing Market by Type
6.4.2 Rest of North America In Vitro Toxicity Testing Market by Technology
6.4.3 Rest of North America In Vitro Toxicity Testing Market by End User
Chapter 7. Company Profiles
7.1 Thermo Fisher Scientific, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 General Electric (GE) Co.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.6 SWOT Analysis
7.3 AstraZeneca PLC
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.4 Catalent, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional & Segmental Analysis
7.4.4 Research & Development Expenses
7.5 Laboratory Corporation of America Holdings (Covance, Inc.)
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Recent strategies and developments:
7.5.4.1 Acquisition and Mergers:
7.6 Acacia Pharma Group Plc
7.6.1 Company Overview
7.7 GlaxoSmithKline PLC (TESARO, Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Helsinn Healthcare SA.
7.8.1 Company Overview
7.9 Heron Therapeutics, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Research & Development Expenses
Unique Offerings 
